Company Filing History:
7 out of 8,693 
4 out of 1,942 
1 out of 1 Years Active: 1997-2023
Title: Alan S Cross: Innovator in Immunogenic Compositions
Introduction:
In the world of medical advancements, inventors play a pivotal role in developing technologies that save lives and prevent diseases. Alan S Cross, a renowned inventor hailing from Chevy Chase, MD, has made significant contributions to the field of nosocomial infection prevention and treatment. With an impressive portfolio of 11 patents, Cross has demonstrated his passion for creating innovative solutions to combat infectious diseases.
Latest Patents:
One of Alan S Cross' recent patents focuses on immunogenic compositions, specifically targeting the prevention and/or treatment of nosocomial infections. Nosocomial infections are infections acquired in a healthcare setting, which can pose serious risks to patients. Cross's technology provides a significant breakthrough in the development of preventive measures against such infections.
Another remarkable invention by Cross is a broad-spectrum conjugate vaccine designed to prevent klebsiella pneumoniae and pseudomonas aeruginosa infections. The patented technology utilizes conjugates and vaccine compositions containing aflagellin or antigenic fragments linked to surface polysaccharide antigens. These vaccines have the potential to offer protection against these harmful bacteria, reducing the prevalence of associated infections.
Career Highlights:
Throughout his career, Alan S Cross has worked with esteemed organizations such as the University of Maryland, Baltimore, and the United States of America, as represented by the Secretary of the appropriate department. His dedication to research and innovation has led him to develop groundbreaking inventions in the field of medicine and public health.
Collaborations:
Collaboration has been a key aspect of Cross's work. Collaborating with peers in the industry has allowed him to exchange ideas, garner valuable insights, and collectively work towards achieving innovative solutions. Some of his notable collaborators include Apurba K Bhattacharjee and Jerald C Sadoff, who have undoubtedly contributed to the successful development of his patented inventions.
Conclusion:
Alan S Cross's relentless pursuit of preventing and treating nosocomial infections has resulted in revolutionary advancements in the field of immunogenic compositions. With 11 patents to his name, Cross has established himself as a prominent figure in medical innovation. Through his collaborations and contributions to esteemed institutions, his inventions have the potential to make a lasting impact on healthcare practices worldwide. Alan S Cross's work stands as a testament to the power of innovation and its profound benefits to society as a whole.
[Disclaimer: The information provided in this article is based on the available data about Alan S Cross and may not encompass his entire career or portfolio.]